Library / Laws / 115th Congress / House Bills / H.R. 4117
H.R. 4117
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2017-10-25 | 16.0K | ⠃⠗⠋ |